Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)

Total Costs & Expenses

$3.99B

Quarterly · Period ending: · USD

TEVA logo

TEVA Total Costs & Expenses

Latest reported$3.99B
TEVA Quarterly Total Costs & Expenses ($0.00 → $3.99B)
High-resolution chart · PNG

TEVA total costs & expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Teva Pharmaceutical Industries Limited American Depositary Shares Total Costs & Expenses — Quarterly (USD)
Period endingTotal Costs & Expenses (USD)
3,993,000,000
3,329,000,000
4,411,000,000
3,598,000,000
3,721,000,000
3,372,000,000
4,258,000,000
4,382,000,000
4,169,000,000
4,037,000,000
3,701,000,000
3,506,000,000
4,532,000,000
3,674,000,000
4,738,000,000
3,176,000,000
4,735,000,000
4,374,000,000
4,022,000,000
3,264,000,000
3,328,000,000
3,548,000,000
4,047,000,000
8,320,000,000
3,697,000,000
4,166,000,000
4,319,000,000
3,555,000,000
3,681,000,000
3,641,000,000
4,024,000,000
3,871,000,000
3,956,000,000
4,134,000,000
4,634,000,000
4,702,000,000
4,583,000,000
4,475,000,000
5,226,000,000
4,675,000,000
3,799,000,000
3,551,000,000
3,687,000,000
3,509,000,000
3,635,000,000
3,707,000,000
3,984,000,000
3,904,000,000
3,951,000,000
3,943,000,000
4,395,000,000
4,045,000,000
3,971,000,000
3,942,000,000
4,280,000,000
3,901,000,000
3,932,000,000
4,025,000,000
4,532,000,000
3,243,000,000
3,615,000,000
3,184,000,000
3,303,000,000
3,009,000,000
2,729,000,000
2,785,000,000
2,892,000,000
2,700,000,000
2,698,000,000
2,595,000,000
3,546,000,000
2,192,000,000
2,185,000,000
1,893,000,000
1,915,000,000
1,715,000,000
1,749,000,000
1,634,000,000
1,854,600,000
1,562,100,000
1,497,200,000
1,367,500,000
1,039,800,000
1,005,100,000
918,600,000
974,000,000
987,400,000
929,600,000
879,300,000
828,200,000
715,500,000
615,500,000
482,500,000
578,100,000
587,600,000
509,700,000
460,400,000
436,900,000
455,314,000
406,700,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.